Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Discovery of a novel epigenetic cancer marker related to the oxidative status of human blood.

Schöttker B, Zhang Y, Heiss JA, Butterbach K, Jansen EH, Bewerunge-Hudler M, Saum KU, Holleczek B, Brenner H.

Genes Chromosomes Cancer. 2015 Sep;54(9):583-94. doi: 10.1002/gcc.22271. Epub 2015 Jul 14.

PMID:
26173806
2.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Sobral-Leite M, Wesseling J, Smit VT, Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM, Coulson P, Patrycja G, Schellens JH, Fagerholm R, Heikkilä P, Aittomäki K, Blomqvist C, Provenzano E, Ali HR, Figueroa J, Sherman M, Lissowska J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Phillips KA; kConFab/AOCS Investigators, Couch FJ, Olson JE, Vachon C, Visscher D, Brenner H, Butterbach K, Arndt V, Holleczek B, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, van de Water B, Broeks A, Chang-Claude J, Chenevix-Trench G, Easton DF, Pharoah PD, García-Closas M, de Graauw M, Schmidt MK.

BMC Med. 2015 Jul 2;13:156. doi: 10.1186/s12916-015-0392-6.

3.

Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.

Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H; GEKID Cancer Survival Working Group.

Br J Haematol. 2015 Jun 30. doi: 10.1111/bjh.13537. [Epub ahead of print]

PMID:
26123295
4.

Social disparities in Disease Management Programmes for coronary heart disease in Germany: a cross-classified multilevel analysis.

Bozorgmehr K, Maier W, Brenner H, Saum KU, Stock C, Miksch A, Holleczek B, Szecsenyi J, Razum O.

J Epidemiol Community Health. 2015 Jun 16. pii: jech-2014-204506. doi: 10.1136/jech-2014-204506. [Epub ahead of print]

5.

Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis.

Buttmann-Schweiger N, Klug SJ, Luyten A, Holleczek B, Heitz F, du Bois A, Kraywinkel K.

PLoS One. 2015 May 28;10(5):e0128073. doi: 10.1371/journal.pone.0128073. eCollection 2015.

6.

Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular Mortality.

Zhang Y, Schöttker B, Florath I, Stock C, Butterbach K, Holleczek B, Mons U, Brenner H.

Environ Health Perspect. 2015 May 27. [Epub ahead of print]

7.

Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium.

Ordóñez-Mena JM, Schöttker B, Fedirko V, Jenab M, Olsen A, Halkjær J, Kampman E, de Groot L, Jansen E, Bueno-de-Mesquita HB, Peeters PH, Siganos G, Wilsgaard T, Perna L, Holleczek B, Pettersson-Kymmer U, Orfanos P, Trichopoulou A, Boffetta P, Brenner H.

Eur J Epidemiol. 2015 May 15. [Epub ahead of print]

PMID:
25977096
8.

Survival of patients with gastric lymphoma in Germany and the United States.

Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H; GEKID Cancer Survival Working Group.

J Gastroenterol Hepatol. 2015 May 13. doi: 10.1111/jgh.12989. [Epub ahead of print]

PMID:
25967274
9.

Association between Oxidative Stress and Frailty in an Elderly German Population: Results from the ESTHER Cohort Study.

Saum KU, Dieffenbach AK, Jansen EH, Schöttker B, Holleczek B, Hauer K, Brenner H.

Gerontology. 2015 Apr 24. [Epub ahead of print]

PMID:
25924722
10.

Common germline polymorphisms associated with breast cancer-specific survival.

Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, Rahman N, Nevanlinna H, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, van Ongeval C, Nordestgaard BG, Nielsen SF, Flyger H, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Olsen JE, Hallberg E, Vachon C, Knight JA, Glendon G, Mulligan AM, Broeks A, Cornelissen S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Butterbach K, Holleczek B, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Manoukian S, Ficarazzi F, Beckmann MW, Hein A, Ekici AB, Balleine R, Phillips KA; kConFab Investigators, Benitez J, Zamora MP, Perez JI, Menéndez P, Jakubowska A, Lubinski J, Gronwald J, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S; NBCS Investigators, Evans DG, Abraham J, Earl H, Poole CJ, Hiller L, Dunn JA, Bowden S, Yang R, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson S, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, Garcia-Closas M, Couch FJ, Chenevix-Trench G, Mannermaa A, Andrulis IL, Hall P, Chang-Claude J, Easton DF, Bojesen SE, Cox A, Fasching PA, Pharoah PD, Schmidt MK.

Breast Cancer Res. 2015 Apr 22;17(1):58. doi: 10.1186/s13058-015-0570-7.

11.

Identification of novel genetic markers of breast cancer survival.

Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Couch FJ, Olson JE, Vachon C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Broeks A, Hogervorst FB, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cox A, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Dieffenbach AK, Arndt V, Holleczek B, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Bonanni B, Mariani P, Fasching PA, Beckmann MW, Hein A, Ekici AB, Chenevix-Trench G, Balleine R; kConFab Investigators, Phillips KA, Benitez J, Zamora MP, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S, Evans DG, Abraham JE, Earl HM, Hiller L, Dunn JA, Bowden S, Berg C, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson SE, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, García-Closas M, Hall P, Easton DF, Eccles DM, Rahman N, Nevanlinna H, Pharoah PD.

J Natl Cancer Inst. 2015 Apr 18;107(5). pii: djv081. doi: 10.1093/jnci/djv081. Print 2015 May.

12.

Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008-2010.

Bozorgmehr K, San Sebastian M, Brenner H, Razum O, Maier W, Saum KU, Holleczek B, Miksch A, Szecsenyi J.

Int J Equity Health. 2015 Mar 10;14(1):28. doi: 10.1186/s12939-015-0155-1.

13.

F2RL3 methylation, lung cancer incidence and mortality.

Zhang Y, Schöttker B, Ordóñez-Mena J, Holleczek B, Yang R, Burwinkel B, Butterbach K, Brenner H.

Int J Cancer. 2015 Oct 1;137(7):1739-48. doi: 10.1002/ijc.29537. Epub 2015 Apr 17.

PMID:
25821117
14.

Comparison of the performance of 2 GFR estimating equations using creatinine and cystatin C to predict adverse outcomes in elderly individuals.

Emrich IE, Pickering JW, Schöttker B, Lennartz CS, Rogacev KS, Brenner H, Rothenbacher D, Holleczek B, Saum KU, Fliser D, Heine GH.

Am J Kidney Dis. 2015 Apr;65(4):636-8. doi: 10.1053/j.ajkd.2014.12.006. Epub 2015 Jan 23. No abstract available.

PMID:
25620662
15.

Utilisation of psychosocial and informational services in immigrant and non-immigrant German cancer survivors.

Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V.

Psychooncology. 2015 Aug;24(8):919-25. doi: 10.1002/pon.3742. Epub 2014 Dec 19.

PMID:
25529132
16.

Cognitive impairment, all-cause and cause-specific mortality among non-demented older adults.

Perna L, Wahl HW, Mons U, Saum KU, Holleczek B, Brenner H.

Age Ageing. 2015 May;44(3):445-51. doi: 10.1093/ageing/afu188. Epub 2014 Dec 2.

PMID:
25468013
17.

Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES).

O'Doherty MG, Jørgensen T, Borglykke A, Brenner H, Schöttker B, Wilsgaard T, Siganos G, Kavousi M, Hughes M, Müezzinler A, Holleczek B, Franco OH, Hofman A, Boffetta P, Trichopoulou A, Kee F.

Eur J Epidemiol. 2014 Dec;29(12):887-97. doi: 10.1007/s10654-014-9954-8. Epub 2014 Nov 25.

PMID:
25421782
18.

Recent cancer survival in Germany: an analysis of common and less common cancers.

Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

Int J Cancer. 2015 Jun 1;136(11):2649-58. doi: 10.1002/ijc.29316. Epub 2014 Nov 26.

PMID:
25380088
19.
20.

Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.

Rusner C, Wolf K, Bandemer-Greulich U, Engel J, Stegmaier C, Holleczek B, Schubert-Fritschle G, Tillack A, Stang A.

Breast Cancer Res. 2014 Oct 3;16(5):452. doi: 10.1186/s13058-014-0452-4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk